Solural Pharma receives an updated Manufacturing and Importation Authorisation from the Danish Health and Medicines Authority expanding its manufacturing capabilities to also include manufacturing of inhalation products as well as for physical chemical testing of Marketed products.
- New patent acquisition agreement November 16, 2022
- New Eurasia patent December 25, 2020
- New Manufacturing Authorisation December 18, 2020
If you are interested in joining Solural Pharma ApS, we are seeking professionals, technicians and consultants with expertise within drug development. Please contact
firstname.lastname@example.org for more information about available positions.